RISK OF NONMELANOMA SKIN CANCER IN ITALIAN ORGAN TRANSPLANT RECIPIENTS. A REGISTRY-BASED STUDY
Luigi Naldi(Centro Studi GISED), Giuseppe Remuzzi(Mario Negri Institute for Pharmacological Research), Silvia Lovati(Azienda Ospedaliero-Universitaria delle Marche), Anna Belloni Fortina(University of Padua), Eliana Gotti(Azienda Ospedaliero-Universitaria delle Marche), Andrea Diociaiuti(Bambino Gesù Children's Hospital), Donatella Schena(University of Verona), Ilaria Lesnoni La Parola(San Gallicano Hospital), T. Cainelli(Azienda Ospedaliero-Universitaria delle Marche), Annalisa Barba(University of Verona), Andrea Peserico(University of Padua), Cinzia Masini(Università Cattolica del Sacro Cuore), G Nanni(Università Cattolica del Sacro Cuore), Gianpaolo Tessari(University of Verona), Stefano Piaserico(University of Padua)
Cited by 117
Related Papers
The Global Burden of Cancer 2013
|JAMA Oncology|2015|2.8k
von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic Syndrome
|New England Journal of Medicine|1998|1.7k
Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
|New England Journal of Medicine|2013|990
Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria
|The Lancet|1999|909
Overview of Complement Activation and Regulation
|Seminars in Nephrology|2013|864